参考资料:[1] ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing,Retrieved March 28, 2023, from https://arrivent.com/press-release/arrivent-biopharma-closes-155-million-oversubscribed-series-b-financing/[2] ArriVent Snags $155M for NSCLC Treatment in Record Low Series B Period,Retrieved March 28, 2023, from https://www.biospace.com/article/arrivent-snags-155m-for-nsclc-drug-in-record-low-series-b-period/